These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 31625195

  • 1. Identification SYT13 as a novel biomarker in lung adenocarcinoma.
    Zhang L, Fan B, Zheng Y, Lou Y, Cui Y, Wang K, Zhang T, Tan X.
    J Cell Biochem; 2020 Feb; 121(2):963-973. PubMed ID: 31625195
    [Abstract] [Full Text] [Related]

  • 2. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K, Luo J, Shao C, Ren Z, Sun S, Zhu Y, Zhou H, Jiang Z, Li X, Gu W, Xu Y, Qiang Y, Ren B, Xu L, Wu H, Shen Y.
    Med Sci Monit; 2020 Feb 28; 26():e920351. PubMed ID: 32108133
    [Abstract] [Full Text] [Related]

  • 3. Silencing of synaptotagmin 13 inhibits tumor growth through suppressing proliferation and promoting apoptosis of colorectal cancer cells.
    Li Q, Zhang S, Hu M, Xu M, Jiang X.
    Int J Mol Med; 2020 Jan 28; 45(1):234-244. PubMed ID: 31939613
    [Abstract] [Full Text] [Related]

  • 4. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
    Ko PH, Lenka G, Chen YA, Chuang EY, Tsai MH, Sher YP, Lai LC.
    Int J Oncol; 2020 Jan 28; 56(1):165-177. PubMed ID: 31789397
    [Abstract] [Full Text] [Related]

  • 5. Role of synaptotagmin 13 (SYT13) in promoting breast cancer and signaling pathways.
    Zhang YD, Zhong R, Liu JQ, Sun ZX, Wang T, Liu JT.
    Clin Transl Oncol; 2023 Jun 28; 25(6):1629-1640. PubMed ID: 36630025
    [Abstract] [Full Text] [Related]

  • 6. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S, Wang X, Zhang Z, Liu D.
    Thorac Cancer; 2020 Mar 28; 11(3):526-536. PubMed ID: 31962007
    [Abstract] [Full Text] [Related]

  • 7. KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
    Ji Z, Pan X, Shang Y, Ni DT, Wu FL.
    Tissue Cell; 2019 Dec 28; 61():44-50. PubMed ID: 31759406
    [Abstract] [Full Text] [Related]

  • 8. KRT6A Promotes EMT and Cancer Stem Cell Transformation in Lung Adenocarcinoma.
    Yang B, Zhang W, Zhang M, Wang X, Peng S, Zhang R.
    Technol Cancer Res Treat; 2020 Dec 28; 19():1533033820921248. PubMed ID: 32329414
    [Abstract] [Full Text] [Related]

  • 9. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB, Yang XP, Zhou PX, Yang XA, Yin B.
    Genes Genomics; 2020 Feb 28; 42(2):179-188. PubMed ID: 31768767
    [Abstract] [Full Text] [Related]

  • 10. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y, Luo L, Xie Y, Zhao Y, Yao J, Liu X.
    Mol Carcinog; 2020 May 28; 59(5):503-511. PubMed ID: 32133692
    [Abstract] [Full Text] [Related]

  • 11. Serous IFNA3 predicts unfavorable prognosis in lung cancer via abnormal activation of AKT signaling.
    Ge Q, Cong P, Ji Y.
    IUBMB Life; 2019 Nov 28; 71(11):1806-1814. PubMed ID: 31419016
    [Abstract] [Full Text] [Related]

  • 12. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
    Wei X, Zhang K, Qin H, Zhu J, Qin Q, Yu Y, Wang H.
    BMC Cancer; 2018 May 29; 18(1):600. PubMed ID: 29843634
    [Abstract] [Full Text] [Related]

  • 13. Annexin A10 Expression as a Novel Prognostic Marker in Lung Adenocarcinoma.
    Yumura M, Nagano T, Jimbo N, Dokuni R, Kiriu T, Tanaka Y, Tachihara M, Itoh T, Maniwa Y, Nishimura Y, Kobayashi K.
    Anticancer Res; 2022 Mar 29; 42(3):1289-1294. PubMed ID: 35220218
    [Abstract] [Full Text] [Related]

  • 14. [DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation].
    Shen J, Xi M.
    Zhongguo Fei Ai Za Zhi; 2021 Jul 20; 24(7):453-460. PubMed ID: 34134185
    [Abstract] [Full Text] [Related]

  • 15. CALU promotes lung adenocarcinoma progression by enhancing cell proliferation, migration and invasion.
    Li Y, Sun S, Zhang H, Jing Y, Ji X, Wan Q, Liu Y.
    Respir Res; 2024 Jul 05; 25(1):267. PubMed ID: 38970088
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-195 suppresses the progression of lung adenocarcinoma by directly targeting apelin.
    Zhou Y, Zhao M, Du Y, Liu Y, Zhao G, Ye L, Li Q, Li H, Wang X, Liu X, Guo Y, Liu J, Huang Y.
    Thorac Cancer; 2019 Jun 05; 10(6):1419-1430. PubMed ID: 31070305
    [Abstract] [Full Text] [Related]

  • 17. [Effects of heme oxygenase-1 knockdown on proliferation, invasion and metastasis of lung adenocarcinoma A549 cells and its mechanism].
    Cao L, Suo XJ, Jiang W, Zhao D, Yan XJ, Yang J, Ma ZY.
    Zhonghua Zhong Liu Za Zhi; 2019 Nov 23; 41(11):813-819. PubMed ID: 31770847
    [Abstract] [Full Text] [Related]

  • 18. C1QTNF6 as a novel biomarker regulates cellular behaviors in A549 cells and exacerbates the outcome of lung adenocarcinoma patients.
    Han M, Wang B, Zhu M, Zhang Y.
    In Vitro Cell Dev Biol Anim; 2019 Sep 23; 55(8):614-621. PubMed ID: 31292940
    [Abstract] [Full Text] [Related]

  • 19. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
    Lee KY, Shueng PW, Chou CM, Lin BX, Lin MH, Kuo DY, Tsai IL, Wu SM, Lin CW.
    Cancer Sci; 2020 May 23; 111(5):1652-1662. PubMed ID: 32133706
    [Abstract] [Full Text] [Related]

  • 20. miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.
    Wang J, Yao S, Diao Y, Geng Y, Bi Y, Liu G.
    Thorac Cancer; 2020 Jun 23; 11(6):1396-1405. PubMed ID: 32220063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.